PAX7 and breast carcinoma: This reciprocal feedback may also apply to breast cancer, where PAX7 can regulate components of the Wnt/β‐catenin pathway, such as β‐catenin, Wnt ligands, or inhibitors such as GSK3β, while modulating chromatin accessibility or recruiting coregulators.